Island Pharmaceuticals Limited (ASX:ILA) Insider Acquires A$30,000.00 in Stock

Island Pharmaceuticals Limited (ASX:ILA) insider David Foster purchased 500,000 shares of the business’s stock in a transaction dated Wednesday, March 5th. The shares were purchased at an average price of A$0.06 ($0.04) per share, with a total value of A$30,000.00 ($18,987.34).

Island Pharmaceuticals Stock Performance

The firm has a market cap of $25.60 million, a P/E ratio of -4.85 and a beta of 0.40. The company has a debt-to-equity ratio of 27.78, a quick ratio of 8.28 and a current ratio of 2.45.

About Island Pharmaceuticals

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; and research collaboration agreement with Compounds Australia, a drug library containing various molecules that could be searched for drug re-purposing and pipeline development.